School of Nursing and Midwifery, University of Ghana, Legon, Accra, Ghana; Christian Health Association of Ghana, Accra, Ghana.
Yale School of Nursing, Yale University, New Haven, CT, USA.
Diabetes Res Clin Pract. 2023 Jul;201:110731. doi: 10.1016/j.diabres.2023.110731. Epub 2023 May 24.
This review aimed to estimate the level of acceptance of COVID-19 vaccine among persons with diabetes.
A systematic search was conducted on PubMed, MEDLINE, Embase, and CINAHL to identify relevant studies for this review. A random-effects meta-analysis was performed to generate an overall estimate of vaccine acceptance. The I statistic was used to quantify the degree of variation across studies, and subgroup analysis was conducted to identify the sources of heterogeneity. The review was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA).
This review included 18 studies involving 11,292 diabetes patients. The pooled prevalence of COVID-19 vaccine acceptance among persons with diabetes was 76.1% (95% CI: 66.7%-83.5%). The pooled prevalence across the continent ranged from 68.9% (95% CI: 47.8%-84.3%) in Asia to 82.1% (95% CI: 80.2%-83.8%) in Europe. Barriers to vaccine acceptance included misinformation, lack of information, mistrust, health concerns, and external influences.
The barriers to vaccine acceptance identified in this review, could inform the formulation of health policies and public health interventions that are specifically tailored to address the needs of persons with diabetes.
本综述旨在评估糖尿病患者对 COVID-19 疫苗的接受程度。
系统检索 PubMed、MEDLINE、Embase 和 CINAHL 以确定本综述相关研究。采用随机效应荟萃分析生成疫苗接受度的总体估计值。使用 I 统计量来量化研究间的变异程度，并进行亚组分析以确定异质性的来源。本综述按照系统评价和荟萃分析的 Preferred Reporting Items（PRISMA）进行。
本综述纳入了 18 项研究，涉及 11292 名糖尿病患者。糖尿病患者对 COVID-19 疫苗的接受率为 76.1%（95%CI：66.7%-83.5%）。不同大陆的疫苗接受率范围从亚洲的 68.9%（95%CI：47.8%-84.3%）到欧洲的 82.1%（95%CI：80.2%-83.8%）。疫苗接受的障碍包括错误信息、缺乏信息、不信任、健康问题和外部影响。
本综述确定的疫苗接受障碍，可以为制定专门针对糖尿病患者需求的卫生政策和公共卫生干预措施提供信息。
